PlainVisa
2026 data Public-data reference Official source

Cycle Pharmaceuticals Inc.

A DOL Labor Condition Application record spanning FY2023–2025. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
3
DOL-certified
100%
Median offered wage
$116,743

Boston, MA NAICS: 424210

How many H-1B LCA filings list Cycle Pharmaceuticals Inc.?

U.S. Department of Labor's OFLC discloses 3 Labor Condition Application filings naming Cycle Pharmaceuticals Inc. from FY2023 through FY2025, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

The verdict

Cycle Pharmaceuticals Inc. is listed in 3 DOL LCA filings, more filings than 67% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $116,743. This is not a USCIS approval, hiring, or sponsorship ranking.

3
DOL LCA filings, FY2023–FY2025
100%
DOL-certified
$116,743
median offered wage
Top 33%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2025). Based in Boston, MA.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Cycle Pharmaceuticals Inc. vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

3 52221st of 122824 higher than 70,603 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2025

LCA filing shape · Cycle Pharmaceuticals Inc.

Derived from this employer's disclosed LCAs on file (FY2023–FY2025), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $90,230$135,000 .

Title concentration

  • Director, Market Access & Distribution 2 · 66.7% · $130,000
  • Manager, Market Access & Distribution 1 · 33.3% · $90,230

Worksite counties

  • BOSTON CITY, MA 3 · 100%

Boston City, MA worksite concentration

Only 3 LCAs on file for Cycle Pharmaceuticals Inc., and 100% land in BOSTON CITY, MA. Treat rates as descriptive of a small sample. DOL cert on file: 100%.

Certification Rate

100%

Very high DOL cert

Avg. Salary

$116,743

Near portal avg

Total Workers

3

Small worker count

Wage vs. DOL Minimum

+9.5%

At/above DOL floor

national avg +17.8%

Typical DOL Wage Level

Qualified (Level II)

66.7% of LCA filings

Full-Time Positions

100%

Primary Worksite County

BOSTON CITY, MA

100% of LCA filings

Recent LCA Filings

Latest H-1B labor condition applications filed by Cycle Pharmaceuticals Inc.

Job Title Location Salary Status Year
Director, Market Access & Distribution Boston, MA $125,000 Certified FY2025
Director, Market Access & Distribution Boston, MA $135,000 Certified FY2023
Manager, Market Access & Distribution Boston, MA $90,230 Certified FY2023

Nationwide peers near Cycle Pharmaceuticals Inc.'s 3-LCA band

Cross-state DOL neighbors for Cycle Pharmaceuticals Inc. - LCA filing-count and offered-wage axes, outside MA.

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($116,743 here).

Disclaimer: Informational only, not professional advice.

Read with Cycle Pharmaceuticals Inc.

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps TRACE-BOOK · CERT-LOCK · WAGE-PAR.

What to do with this profile

Use the DOL LCA record for Cycle Pharmaceuticals Inc. to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.